Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.340
+0.130 (5.88%)
Sep 18, 2025, 3:13 PM EDT - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $145.12 million as of September 18, 2025. Its market cap has decreased by -35.04% in one year.
Market Cap
145.12M
Enterprise Value
73.78M
1-Year Change
-35.04%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $145.12M, a decrease of -72.29%. That is a compound annual growth rate of -27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 137.06M | 47.75% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.04B |
| Johnson & Johnson | 424.47B |
| AbbVie | 382.48B |
| UnitedHealth Group | 309.05B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 231.25B |